ID 112048
Title Alternative
Current and future status of the cell-free and concentrated ascites reinfusion therapy (CART)
Author
Keywords
refractory ascites
pleural effusion
cell-free and concentrated ascites reinfusion therapy
Content Type
Journal Article
Description
Cell-free and concentrated ascites reinfusion therapy (CART) is an effective and safe therapy for patients with refractory ascites or pleural effusion. CART was mainly performed conventionally for patients with liver cirrhosis. In addition to the improvement of the device and procedure, CART has been performed widely for patients with advanced cancer by progress of the intraperitoneal chemotherapy. Furthermore, cancer therapy that applies cancer cells obtained by filtration process is considered, and CART attracts attention as one of the important therapies to support future cancer therapy. However, the therapeutic method of CART has not been standardized yet, and the accumulated evidence about its effectiveness and safety is insufficient. Therefore, aiming at the development of guidelines to perform CART safely and effectively, standardization of the CART procedure and evaluation of its efficacy and safety, establishment of an educational system, and environmental improvement, including the development of equipment, are necessary.
Journal Title
Shikoku Acta Medica
ISSN
00373699
NCID
AN00102041
Publisher
徳島医学会
Volume
73
Issue
5-6
Start Page
257
End Page
268
Sort Key
257
Published Date
2017-12-25
FullText File
language
jpn
TextVersion
Publisher
departments
Medical Sciences